Liquidia (FRA:LT4) Price-to-Tangible-Book : 11.94 (As of Jun. 22, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Liquidia Price-to-Tangible-Book?

As of today (2024-06-22), Liquidia's share price is €11.37. Liquidia's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was €0.95. Hence, Liquidia's Price to Tangible Book Ratio of today is 11.94.

The historical rank and industry rank for Liquidia's Price-to-Tangible-Book or its related term are showing as below:

FRA:LT4' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.07 Med: 4.96 Max: 26.9
Current: 11.6

During the past 8 years, Liquidia's highest Price to Tangible Book Ratio was 26.90. The lowest was 2.07. And the median was 4.96.

FRA:LT4's Price-to-Tangible-Book is ranked worse than
90.32% of 1209 companies
in the Biotechnology industry
Industry Median: 2.6 vs FRA:LT4: 11.60

A closely related ratio is called PB Ratio. As of today, Liquidia's share price is €11.37. Liquidia's Book Value per Sharefor the quarter that ended in Mar. 2024 was €1.04. Hence, Liquidia's P/B Ratio of today is 10.93.

Liquidia Price-to-Tangible-Book Historical Data

The historical data trend for Liquidia's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Liquidia Price-to-Tangible-Book Chart

Liquidia Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

1.88

4.33

4.96

20.15

Liquidia Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Tangible-Book	Get a 7-Day Free Trial															5.73	9.82	10.17	20.15	14.47

Competitive Comparison of Liquidia's Price-to-Tangible-Book

For the Biotechnology subindustry, Liquidia's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Liquidia's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Liquidia's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Liquidia's Price-to-Tangible-Book falls into.

Liquidia Price-to-Tangible-Book Calculation

Liquidia's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2024 )
	=	11.37	/	0.952
	=	11.94

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Liquidia Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Liquidia's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Liquidia (FRA:LT4) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Liquidia Corp (FRA:LT4) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

LQDA:USA

Address

419 Davis Drive, Suite 100, Morrisville, NC, USA, 27560

Website

https://www.liquidia.com

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH). It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles designed to improve the safety, efficacy, and performance of a wide range of therapies. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension.

Liquidia (FRA:LT4) Headlines

No Headlines